Lipigon Pharmaceuticals AB (LPGO) — Net Asset Quality Index
Lipigon Pharmaceuticals AB (LPGO) has a Net Asset Quality Index of 68.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr11.49 Million minus total liabilities of Skr3.57 Million yields net assets of Skr7.91 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of Lipigon Pharmaceuticals AB to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Lipigon Pharmaceuticals AB Net Asset Quality Index Over Time (2017–2025)
This chart shows how Lipigon Pharmaceuticals AB's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the index stands at 68.9%, representing net assets of Skr7.91 Million against total assets of Skr11.49 Million SEK. See working capital position of Lipigon Pharmaceuticals AB to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Lipigon Pharmaceuticals AB (2017–2025)
The table below presents the year-by-year Net Asset Quality Index for Lipigon Pharmaceuticals AB from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Lipigon Pharmaceuticals AB.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 68.9% | Skr7.91 Million | Skr11.49 Million | Skr3.57 Million | ▲ +16.5 pp |
| 2024 | 52.4% | Skr7.76 Million | Skr14.82 Million | Skr7.06 Million | ▼ -32.3 pp |
| 2023 | 84.6% | Skr28.44 Million | Skr33.60 Million | Skr5.16 Million | ▲ +48.9 pp |
| 2022 | 35.8% | Skr3.87 Million | Skr10.82 Million | Skr6.95 Million | ▼ -42.2 pp |
| 2021 | 78.0% | Skr22.96 Million | Skr29.43 Million | Skr6.47 Million | ▼ -7.2 pp |
| 2020 | 85.2% | Skr12.98 Million | Skr15.24 Million | Skr2.26 Million | ▲ +17.6 pp |
| 2019 | 67.6% | Skr2.17 Million | Skr3.21 Million | Skr1.04 Million | ▲ +441.8 pp |
| 2018 | -374.2% | Skr-842.00K | Skr225.00K | Skr1.07 Million | ▼ -439.2 pp |
| 2017 | 65.0% | Skr1.15 Billion | Skr1.77 Billion | Skr619.85 Million | — |